Generics go softer on Zyprexa, boosting Lilly's Q1; Amgen profits beat estimates;

 @FiercePharma: Zyprexa sales fell off a (patent) cliff , but Lilly still beat analyst forecasts for Q1--ReutersNews | Follow @FiercePharma

> Eli Lilly's ($LLY) first-quarter sales beat its forecast, thanks to milder-than-expected erosion of Zyprexa sales and strong growth of its Cymbalta antidepressant. Report

> Amgen ($AMGN) reported street-beating profits of $1.18 billion, or $1.48 per share, as sales of several products grew by double digits, offsetting ongoing declines in anemia drugs. Article

> India's Ranbaxy Laboratories launched its malaria drug Synriam in its home country, planning to it move into other Asian countries, Africa and South America as well. Item

> Italy's Recordati bought the German rights to 6 over-the-counter drugs from Johnson & Johnson units Cilag and McNeil. Story

> Questcor Pharmaceuticals ($QCOR) first-quarter profits beat analyst estimates on increasing adoption of its multiple sclerosis drug Acthar. More

> ViroPharma lost its court bid to stop a generic version of its antibiotic Vancocin. News

> Botox's active ingredient may help people with the most frequent migraines, but offers little benefit to those whose migraines are less frequent. Report

Biotech News

 @FierceBiotech: The Biggest R&D Spenders In Biopharma. Special Report | Follow @FierceBiotech

 @JohnCFierce: AVI's retake on IIb DMD data looks to me like a second attempt at a good first impression. Release | Follow @JohnCFierce

 @RyanMFierce: Perakslis: FDA plans to open up some of the FDA's liver tox data on >2000 drugs to outside parties. A good example of data sharing. | Follow @RyanMFierce

> Targacept slashes staff by half in wake of PhIII disaster. News

> Sanofi's Lemtrada beats Rebif in head-to-head MS showdown. Story

> Oregano attacks prostate cancer cells in lab experiment. Article

> Scrambling to add new drugs, Big Pharma is paying big premiums for biotechs. Report

Medical Devices News

 @FierceMedDev: BioMérieux Q1 2012 sales soar, propelled by China, India. Story | Follow @FierceMedDev

> Medtronic bets IT enhancements will boost revenue. Item

> Expanded use for Edwards' Sapien heart valve faces small FDA delay. More

> Analytical instruments, specialty diagnostics drive Thermo Fisher Q1 sales. Article

Drug Delivery News

 @DamianFierce: Tamarisk plans to "turn the industry upside down" with oral insulin platform. News | Follow @DamianFierce

> 'Chemo bomb' nanotechnology effective in halting tumors. Story

> SkyePharma's inhaler takes step toward EMA approval. Article

> Scottish scientists take a page from sci-fi with sonic screwdriver. More

> Australia jumps into life sciences fray with R&D tax credit. Piece

Biomarkers News

> Autism Awareness Month and autism biomarkers. Commentary

> Novo Nordisk, Oxford University seeking inflammation markers. More

> Urine biomarker test for autism on the horizon? Story

> 'Landmark' study splits breast cancer into 10 types. News

And Finally... Leukemia cells have a remembrance of things past. Report